This is not the most recent version of the article. View current version (5 MAR 2015)

Intervention Review

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis

  1. Valerie Waters1,*,
  2. Felix Ratjen2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 14 NOV 2012

Assessed as up-to-date: 2 AUG 2012

DOI: 10.1002/14651858.CD009528.pub2


How to Cite

Waters V, Ratjen F. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD009528. DOI: 10.1002/14651858.CD009528.pub2.

Author Information

  1. 1

    Hospital for Sick Children, Department of Pediatrics, Division of Infectious Diseases, Toronto, Ontario, Canada

  2. 2

    The Hospital for Sick Children, Department of Pediatrics, Toronto, Ontario, Canada

*Valerie Waters, Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada. valerie.waters@sickkids.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 14 NOV 2012

SEARCH

This is not the most recent version of the article. View current version (05 MAR 2015)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M. D. Macià, E. Rojo-Molinero, A. Oliver, Antimicrobial susceptibility testing in biofilm-growing bacteria, Clinical Microbiology and Infection, 2014, 20, 10
  2. 2
    Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J. Stuart Elborn, Michael M. Tunney, Molecular detection of CF lung pathogens: Current status and future potential, Journal of Cystic Fibrosis, 2013, 12, 3, 194

    CrossRef

  3. 3
    Valerie Waters, Felix Ratjen, Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis, The Cochrane Library,